Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06149221 · ClinicalTrials.gov registry record · NA
Penetration-enhanced Direct DBD Non-thermal Plasma for Hair Loss
A NA study of Androgenetic Alopecia, sponsored by Dr. Peter C. Friedman.
- Completed
- Registry status
- NA
- Development phase
- 19
- Enrollment target
- 1
- Study location
NCT06149221 is a NA study of Androgenetic Alopecia that has completed, run by Dr. Peter C. Friedman. The registered enrollment target is 19 participants, below the 164-participant average among 16 other Androgenetic Alopecia trials with a reported enrollment target (88% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06149221, a NA study of Androgenetic Alopecia, has completed, sponsored by Dr. Peter C. Friedman.
- COMPLETED
- Registry status
- NA
- Development phase
- 19 participants
- Enrollment target
- 1
- Study location
Study Summary
In-office applied non-thermal atmospheric pressure plasma treatment on NS pretreated scalp
Conditions Studied
Interventions
- DEVICE NTAP
Study Locations (1)
New York
- The Skin Center Dermatology Group - New City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 19 participants |
| Start Date | 2023-09-01 |
| Est. Completion | 2024-04-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06149221
The ClinicalTrials.gov registry entry for NCT06149221 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 19 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 164-participant average among 16 other Androgenetic Alopecia trials with a reported enrollment target (88% lower). The listed sponsor is Dr. Peter C. Friedman, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Androgenetic Alopecia appearing as the primary indexed condition, and to 1 intervention - of which NTAP is the first listed.
NCT06149221 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT06149221 about?
NCT06149221 is a clinical study titled "Penetration-enhanced Direct DBD Non-thermal Plasma for Hair Loss". In-office applied non-thermal atmospheric pressure plasma treatment on NS pretreated scalp
What is the current status of trial NCT06149221?
This trial is currently completed. It is a NA study. The enrollment target is 19 participants. The study started on 2023-09-01. Estimated completion is 2024-04-12.
What conditions does trial NCT06149221 study?
This clinical trial studies the following conditions: Androgenetic Alopecia.
What interventions are being tested in trial NCT06149221?
The interventions under investigation include: NTAP (DEVICE).
Who is sponsoring clinical trial NCT06149221?
This trial is sponsored by Dr. Peter C. Friedman, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06149221 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Androgenetic Alopecia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Sham LaserCap vs. LaserCap SD vs. LaserCap HD+
RECRUITING · NA
-
1470nm Laser for the Treatment of Androgenetic Alopecia and Scarring Alopecia
RECRUITING · NA
-
The Effect of Platelet Rich Plasma on Non-scarring Alopecia
COMPLETED · NA
-
Computer-Assisted Versus Manual Hair Harvest Comparative Study
COMPLETED · NA
-
A Study Evaluating the Hair Regrowth Efficacy and Safety of ALRV5XR in Female Subjects With Hair Loss
COMPLETED · NA
-
A Randomized, Double-blind Clinical Trial to Evaluate the Safety and Efficacy of the X5 HairLaser for the Treatment of Androgenetic Alopecia in Males
COMPLETED · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.